Ipsat Therapies
Helsinki
About Ipsat Therapies
Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $12.7M
- Last round: Series Unknown (Jan 2006)
Industries & Categories
Biotechnology, Health Diagnostics, Therapeutics
Canonical: https://fsome.com/organization/ipsat-therapies-693464 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.